Bafhameritin-M
Bafhameritin-M Brand names, Bafhameritin-M Analogs
Bafhameritin-M Brand Names Mixture
- No information avaliable
Bafhameritin-M Chemical_Formula
C15H15NO2
Bafhameritin-M RX_link
http://www.rxlist.com/cgi/generic3/mefenamic.htm
Bafhameritin-M fda sheet
Bafhameritin-M msds (material safety sheet)
Bafhameritin-M Synthesis Reference
No information avaliable
Bafhameritin-M Molecular Weight
241.285 g/mol
Bafhameritin-M Melting Point
230-231 oC
Bafhameritin-M H2O Solubility
20 mg/L
Bafhameritin-M State
Solid
Bafhameritin-M LogP
4.041
Bafhameritin-M Dosage Forms
Bolus; Capsule; Capsule (enteric-coated); Drops; Liquid; Lotion; Powder; Powder for solution; Shampoo; Soap bar; Solution; Stick; Syrup; Tablet; Tablet (extended-release)
Bafhameritin-M Indication
For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.
Bafhameritin-M Pharmacology
Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.
Bafhameritin-M Absorption
Mefenamic acid is rapidly absorbed after oral administration.
Bafhameritin-M side effects and Toxicity
Oral, rat LD50: 740 mg/kg. Symptoms of overdose may include severe stomach pain, coffee ground-like vomit, dark stool, ringing in the ears, change in amount of urine, unusually fast or slow heartbeat, muscle weakness, slow or shallow breathing, confusion, severe headache or loss of consciousness.
Bafhameritin-M Patient Information
Bafhameritin-M Organisms Affected
Humans and other mammals
